Elon Musk’s past use of the drug ketamine will not be admissible as evidence in his high-stakes legal battle with OpenAI Inc. and Microsoft Corp., a U.S. federal judge ruled, as the Silicon Valley trial over potential fraud inches closer. At a Friday hearing in Oakland, California, U.S. District Judge Yvonne Gonzalez Rogers clarified the […]
The post Elon Musk’s ketamine use excluded from OpenAI fraud trial appeared first on Nairametrics.